Journal of Commercial Biotechnology — May 2011 issue now available

By /

The May 2011 issue of the Journal of Commercial Biotechnology is now available. The links below will take you to the abstract for each paper:

Volume 17, Issue 2

Editorial

Building biotechnology in OkinawaPDF
Yali Friedman

Commentary

Startup America: What it includes and opportunities for innovatorsPDF
David B Orange
Singapore – Home base for expansion in AsiaPDF
Kian-Teik Beh
Traditional ecological knowledge: Impact on commercial healthPDF
Mohammadali Khalvati, Ikway (Yvonne Fulton) Michine, Wabiska (Zane Bell) Mukwa, Mary Jane Metatawabin

Articles

The growing importance of incorporating US payers into biotechnology drug development decision-makingPDF
Sarah Collins
Anticipating opportunities in industrial biotechnology: Sizing the market and growth scenariosPDF
Peter J Nieuwenhuizen, David Lyon
Founding angels as early stage investment model to foster biotechnology start-upsPDF
Gunter Festel
The economic potential of plant-made pharmaceuticals in the manufacture of biologic pharmaceuticalsPDF
James Kaufman, Nicholas Kalaitzandonakes

From the Classroom

Developing graduate skills for the United Kingdom’s commercial life science sector: Experiences from the ORBIS internship programmePDF
James Gazzard

Legal and Regulatory Updates

EU Legal and Regulatory UpdatePDF
Gerry Kamstra
Impact of recent IP caselaw on biomarkers and personalized medicinePDF
David A Gass
Licensing issues in today’s bankruptcy worldPDF
Michael Schein, Brandon J Fleischman
Limitation of gene patents to functioning DNAPDF
Philip Webber

Book Reviews

Chronicling the development of myozyme: The Cure and Chasing MiraclesPDF
Derek J Francis
Anatomy of a Patent CasePDF
Michael G Sullivan

Biotechblog
Scroll to Top